On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
Iressa Licensed in Europe to Treat Non-Small Cell Lung Cancer
June 16th 2010AstraZeneca's cancer drug Iressa (gefitinib) has been licensed in Europe as a treatment for non–small cell lung cancer (NSCLC). The approval of this oral medication follows the results of the Iressa Pan-Asia Study (IPASS), in which it demonstrated superior progression-free survival compared with intravenous carboplatin/paclitaxel chemotherapy.
Drug Companies Join Together to Accelerate Alzheimer's, Parkinson's Research
June 16th 2010A number of major pharmaceutical companies have agreed to share data from clinical trials for Alzheimer's and Parkinson's disease in an effort to speed the development of new treatments for the brain disorders.
Discovery of Cell-cycle Arrest at Wound Sites May Lead to New Treatment Options
June 15th 2010Researchers at the University of Illinois at Chicago report that senescence, a process previously thought to only occur in cells that suffer DNA damage, also occurs at wound sites, and plays an important role in the formation of scar tissue.
Unexpected Findings from Routine Brain Scans Highlight Need for Guidelines
June 14th 2010The unexpected brain abnormalities in children undergoing routine MRI scans highlights the need for guidelines that help pediatricians talk to parents about what the findings mean, according to Johns Hopkins Children's Center researchers.
The Good, the Bad, and the Ugly: Technology at the Office, Hospital, and Home
This week: measuring the impact of technology on physicians' personal and professional lives, EMRs and the usability factor,Health IT consultants for office-based physicians, and cloud computing in healthcare.
Evaluating Combination Therapy for the Prevention of a First Variceal Bleed
June 10th 2010A team of scientists in Taiwan recently completed a study evaluating the combination of band ligation and nadolol to prevent a first variceal bleed due to cirrhosis, finding that the combination is not effective and may actually increase adverse events.